Click for program


7TH EURASIAN HEMATOLOGY ONCOLOGY SUMMIT - JUNE 27TH& 28TH 2020


JUNE 27TH – DAY 1

15.30 - 15.40 Introduction - Elias Jabbour & Birol Güvenç

15.40 - 16.50 ALL Session - Chairs: Mehmet Ali Özcan - Emin Kaya

15.40 - 15.55 Frontline Therapy - Hagop Kantarjian

15.55 - 16.10 MRD Assessment and Management - Farhad Ravandi

16.10 - 16.25 Management of Relapsed/Refractory ALL - Elias Jabbour

16.25 - 16.40 Philadelphia-Positive ALL - Elias Jabbour

16.40 - 16.50 Q & A

16.50 - 17.35 Novartis Satellite Symposium
Highlights on Managment of Myelofibrosis with Ruxolitinib Haifa Kathrin Al-Ali

17.35 – 17.50 MPN Session – Chairs: Güray Saydam – Filiz Vural
JAK2 Inhibitors in Polycythemia Vera and Essential Thrombocytopenia Tariq Mughal

17.50 – 18.00 Q & A

18.00 – 18.55 CML Session – Chairs: Deniz Sargın – Seçkin Çağırgan

18.00 – 18.15 Frontline CML Management – Hagop Kantarjian

18.15 – 18.30 Management of Relapsed/Refractory CML and Advanced Phases – Elias Jabbour

18.30 – 18.45 Treatment-Free Remission Where and When? – Giuseppe Saglio

18.45 – 18.55 Q & A

18.55 – 19.15 – Break

19.15 – 20.10 MDS Session – Chairs: Mustafa Çetiner - Pervin Topcuoglu

19.15 – 19.30 Biology and Staging Systems – Guillermo Garcia-Manero

19.30 – 19.45 Management of Higher-Risk MDS - Moshe Mittelman

19.45 – 20.00 Management of Lower-Risk MDS – Guillermo Garcia-Manero

20.00 – 20.10 Q & A

20.10 - 20.55 BMS Satellite Symposium – Chair: Levent Undar
Immunotherapy Data Updates in Treatments Classic Hodgkin Lymphoma – Tulin Tuglular


JUNE 28TH – DAY 2

14.30 - 15.15 AMGEN Satellite Symposium - Chair: Mustafa Cetiner
New Era with Carfilzomib In the Treatment of Relapsed Multiple Myeloma Ant Uzay

15.15 - 16.25 AML Session - Chairs: Osman Ilhan - Zafer Gulbas

15.15 - 15.30 How I Treat AML Farhad Ravandi

15.30 - 15.45 Frontline Fit Patients’ Treatment Giovanni Martinelli

15.45 - 16.00 Elderly AML Management Alan Burnett

16.00 - 16.15 Minimal Residual Disease and Role of Maintenance Farhad Ravandi

16.15 - 16.25 Q & A

16.25 - 16.45 - Break

16.45 - 17.40 CLL Session - Chairs: Hakan Goker - Mehmet Turgut

16.45 - 17.00 How I Treat CLL: State of the Art Robin Foa

17.00 - 17.15 Targeted Therapies Panayiotis Panayiotidis

17.15 - 17.30 Management of CLL at the Time of the Covid-19 Pandemic Robin Foa

17.30 - 17.40 Q & A

17.40 - 18.50 MM Session - Chairs: Zahit Bolaman - Duzgun Ozatli

17.40 - 17.55 How I Treat Newly Diagnosed MM Angelo Maiolino

17.55 - 18.10 Real - World Outcomes and Factors Impacting Treatment Choice in RRMM: A Comparison of VRd,KRd and IRd Ajai Chari

18.10 - 18.25 CAR-T Cells Therapies in MM Evangelos Terpos

18.25 - 18.40 Maintenance Therapies in MM- Maria Gavriatopoulou

18.40 - 18.50 Q & A

18.50 - 19.10 - Break

19.10 - 20.20 Lymphoma Session - Chairs: Burhan Ferhanoglu - Mehmet Sonmez

19.10 - 19.25 How I Treat Follicular Lymphoma Gianluca Gaidano

19.25 - 19.40 How I Treat Large Cell Lymphoma Umberto Vitolo

19.40 - 19.55 How I Treat Mantle Cell Lymphoma Charles Schiffer

19.55 - 20.10 How I Treat Hodgkin DiseaseChristian Gisselbrecht

20.10 – 20.20 Q & A

20.20 - 21.15 COVID - 19 Special Session Chairs: Emin Kansu - Gulsum Ozet

20.20 - 20.35 COVID - 19 Treatment in Leukemia Patients Elias Jabbour

20.35 - 20.50 The Profile of a Killer Virus: Mitigating Risks in Patients with Leukemia Roy Chemaly

20.50 - 21.05 Has Covid-19 impacted on the management of Ph+ Leukemias? The situation in Italy Robin Foa

21.05 - 21.15 Q & A

21.15 - 21.30 Rational Drug Use - Chairs: Erdal Kurtoglu - Ismet Aydogdu

21.15 - 21.30 Rational Drug Use Mehmet Yilmaz

21.30 - 21.35 Closing Remarks